Quality of life improvements in patients with PsA who achieve remission or low disease activity targets: results from two clinical trials of ixekizumab at three years of treatment
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Conference item |
| Dil: | English |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2021
|
| Özet: |
|---|